Electromed, Inc. (ELMD)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$28.00+1.41%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ELMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -9.8% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 12.9% |
Growth built into the price is above our model estimate.
The price assumes 22.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
ELMD — CEO transition
Dated 2026-08-25
CEO — James L. Cunniff: The CEO is retiring with a defined timeline and the board has already initiated a search for a successor, indicating an orderly succession rather than a sudden loss.
Why it matters: A drop in cash flow may mean problems or higher costs.
Worry ifCash flow from operations is below $5 million.
Less concerning ifCash flow from operations remains above $5 million.
Why it matters: Gaining market share is important for growth and staying competitive.
Watch forNew data showing an increase in market share in the bronchiectasis market.
Also watch forData showing a decline or stagnation in market share.
Why it matters: If revenue growth speeds up, it could signal a stronger market for Electromed. This would help its performance.
Supportive ifRevenue growth in the Health Care sector rises back toward 10% or higher.
Worry ifRevenue growth is below 10%. It may keep slowing down.
Why it matters: Better operating margins mean lower costs and more profit. This aligns with Electromed's goals.
Supportive ifOperating margin in Q4 FY 2026 exceeds 19.7%.
Worry ifOperating margin in Q4 FY 2026 is below 19.7%.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$184 on $10,000 · ±1.8% | How much price usually moves either way. |
| Bad day | $438 loss on $10,000 · 4.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,148 loss on $10,000 · 41.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Electromed aims for double-digit revenue growth. Falling below this target may signal issues.
Worry ifQ1 2027 revenue growth is at least 15% year over year.
Less concerning ifQ1 2027 revenue growth is below 15% year over year.
Why it matters: Electromed wants to improve margins. Going over 20% shows strong operations.
Supportive ifOperating margin exceeds 20% in Q1 2027.
Worry ifOperating margin is still under 20% in Q1 2027.
Why it matters: New market share gains would show Electromed is successfully growing its presence.
Supportive ifAnnouncement of new partnerships or contracts that increase market share.
Worry ifNo announcements regarding market share growth in the next quarter.
Why it matters: Strong cash flow supports growth and stability. A drop may indicate operational issues.
Worry ifCash flow from operations is at least $7 million in Q1 2027.
Less concerning ifCash flow from operations drops below $7 million in Q1 2027.
Why it matters: The CEO transition may impact company strategy and stability. Clear plans can reassure investors.
Watch forAnnouncement of a new CEO with a clear vision for the company.
Also watch forNo clear succession plan or delays in appointing a new CEO.